Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
September 14, 2024 3:00 AM EDT- 4.3 mg/kg of luveltamab tazevibulin (luvelta) in combination with standard dose of bevacizumab (15Â mg/kg) every 3 weeks resulted in a 56% objective response rate in patients with late-stage ovarian cancer and was selected to be the recommended phase 2 dose (RP2D) -
- Luvelta in combination with bevacizumab demonstrated encouraging preliminary antitumor activity (35% response rate) across all explored dose ranges -
- Expansion at RP2D is ongoing with an additional 23 patients enrolled to date; expansion data are expected in the first half of 2025 -
- No... More
World’s First AutoStore™ Installation Handling Frozen Goods Installed by StrongPoint
September 13, 2024 3:00 AM EDTOSLO, Norway--(BUSINESS WIRE)-- StrongPoint, a retail technology firm focused on making stores and supply chains smarter, have successfully installed the world's first AutoStore Multi-Temperature Solution with a frozen zone. The inaugural site has been installed for Haugaland Storhusholdning, part the Norwegian food distribution group DLVRY, in a facility based in Sveio, Norway.
This press release features multimedia. View the full... More
